The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
BlackRock Sus Adg Intl Eq Ins BRZIX
- NAV / 1-Day Return 12.43 / −0.65 %
- Total Assets 17.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.500%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2.0 Mil
- Status Open
- TTM Yield 2.42%
- Turnover 89%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:13 PM GMT+0
Morningstar’s Analysis BRZIX
Will BRZIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.10 | 532,581 | Healthcare |
ASML Holding NV | 2.78 | 477,649 | Technology |
BlackRock Liquidity T-Fund Instl | 2.28 | 391,438 | Cash and Equivalents |
Novartis AG Registered Shares | 2.07 | 356,243 | Healthcare |
SAP SE | 2.06 | 353,899 | Technology |
AstraZeneca PLC | 1.98 | 341,233 | Healthcare |
Shell PLC | 1.92 | 330,859 | Energy |
Siemens AG | 1.53 | 262,711 | Industrials |
Schneider Electric SE | 1.48 | 254,409 | Industrials |
Nestle SA | 1.31 | 224,913 | Consumer Defensive |